Health
Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study – News-Medical.Net
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, has spread to over 58.8 million worldwide and caused over 1.3 million deaths. The rush to develop safe and effective vaccines to prevent the ongoing spread of SARS-CoV-2 is nearing the finish line as several promising candidates await regulatory body approval for widescale distribution and use.
A team of researchers from the USA and China have engineered a…
-
Noosa News17 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News19 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News15 hours agoFranz Ferdinand: Australian Tour 2025
-
General16 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win